Home » Topics » BioWorld Science

BioWorld Science
RSS

DMC recommends start of part 2 of COVA study of Sarconeos in COVID-19

Jan. 19, 2021

Hangzhou Hertz Pharmaceutical patents casein kinase 1 isoform epsilon inhibitors

Jan. 19, 2021

Preclinical data show SENS-401 reduces loss of residual hearing after cochlear implantation

Jan. 19, 2021

New CDK9/cyclin T1 inhibitors discovered at Medshine Discovery

Jan. 19, 2021

Shanghai Institute of Materia Medica dicloses new hepatitis B virus inhibitors

Jan. 19, 2021

LCP2 is a therapeutic target in lethal sepsis

Jan. 19, 2021

Sobetirome and its prodrug show efficacy in models of EAE

Jan. 19, 2021

Murine model of SARS-CoV-2 infection developed via mRNA transfection of hACE2

Jan. 19, 2021

Enrollment opens in phase II study of vactosertib plus pembrolizumab in NSCLC

Jan. 19, 2021

Eli Lilly initiates phase II study of LY-3462817 in rheumatoid arthritis

Jan. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026